Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report

Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report

Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is one of the primary therapies for improving advanced Parkinson's disease symptoms. Placement of the jejunal catheter through the abdominal wall for drug administration requires a percutaneous interventional procedur...

Full description

Bibliographic Details
Main Authors:	Viviana Torres, Guillermo González-Ortega, Antoni Suárez, Alicia Garrido, Ana Cámara, Yaroslau Compta, Francesc Valldeoriola
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Clinical Parkinsonism & Related Disorders
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590112522000214

Similar Items

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
by: Francesc Valldeoriola, et al.
Published: (2021-11-01)

Acalculous Cholecystitis in Dengue
by: Fatimah Kashif Rasool, et al.
Published: (2022-12-01)

Clinical profile of levodopa-carbidopa-entacapone intestinal gel infusion in patients with advanced Parkinson’s disease
by: Karina A. Atanasova-Ivanova, et al.
Published: (2023-12-01)

Predictive Value of Ambulatory Objective Movement Measurement for Outcomes of Levodopa/Carbidopa Intestinal Gel Infusion
by: Gökçe Kilinçalp, et al.
Published: (2022-01-01)

Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
by: Noriko Nishikawa, et al.
Published: (2022-09-01)

Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients
by: Thomas Müller, et al.
Published: (2022-04-01)

Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
by: Mezin Öthman, et al.
Published: (2021-03-01)

Complications of percutaneous endoscopic gastrostomy-jejunostomy for levodopa/carbidopa infusion in advanced Parkinson's disease
by: Ana Olivares, et al.
Published: (2012-03-01)

Acalculous cholecystitis associated with Ebstein-Barr virus
by: Patricia Mulero-Soto, et al.
Published: (2023-02-01)

Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson’s Disease: An Observational Feasibility Study
by: Trine Hørmann Thomsen, et al.
Published: (2024-01-01)

Xanthonychia Due to Staining From Carbidopa-Levodopa
by: Jonathan Kyle Hwang, et al.
Published: (2023-07-01)

Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
by: Juan Miguel Pilar Bautista, et al.
Published: (2020-01-01)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
by: K. Amande M. Pauls, et al.
Published: (2021-12-01)

Acalculous Cholecystitis Secondary to Epstein-Barr Virus Infection
by: Toshimasa Yamaguchi
Published: (2022-09-01)

Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
by: Thomas Edmund Kimber, et al.
Published: (2019-09-01)

The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
by: Peter A. LeWitt, et al.
Published: (2022-11-01)

Liquid Levodopa/Carbidopa: Old Solution, Forgotten Complication
by: Nirosen Vijiaratnam, et al.
Published: (2017-09-01)

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
by: Evanthia Thomaidou, et al.
Published: (2024-03-01)

Clinical analysis of infectious mononucleosis complicated with acute acalculous cholecystitis
by: Caijie Gao, et al.
Published: (2024-03-01)

Flea-Borne Typhus Presenting with Acalculous Cholecystitis and Severe Anemia
by: Ramya Varadarajan, et al.
Published: (2023-01-01)

Acute Acalculous Cholecystitis Associated with Abscesses—An Unknown Dual Pathology
by: Cristina Gluhovschi, et al.
Published: (2023-02-01)

Levodopa-Carbidopa Intestinal Gel may improve treatment-resistant freezing of gait in Parkinson’s disease
by: Melanie R. Shackleford, et al.
Published: (2022-01-01)

USE OF THREE-COMPONENT LEVODOPA (LEVODOPA/CARBIDOPA/ENTACAPONE) TO CORRECT NOCTURNAL SYMPTOMS OF PARKINSON,S DISEASE
by: T. K. Kulua, et al.
Published: (2015-08-01)

Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation
by: Peter LeWitt, et al.
Published: (2023-01-01)

Acute necrotising pancreatitis and acalculous cholecystitis: a rare presentation of leptospirosis
by: Mohd Sazlly Lim, Sazlyna, et al.
Published: (2014)

HAV‐induced acalculous cholecystitis: A case report and literature review
by: Faranak Salajegheh, et al.
Published: (2023-04-01)

Acute acalculous cholecystitis revealing hepatitis A virus infection in children
by: Arroud Mounir, et al.
Published: (2009-01-01)

The incidence of acute acalculous cholecystitis in critically ill COVID-19 patients
by: Diego Franch-Llasat, et al.
Published: (2022-11-01)

New-onset impulse control disorders after treatment with levodopa–carbidopa intestinal gel in Parkinson's disease
by: A. Contreras Chicote, et al.
Published: (2023-04-01)

New-onset impulse control disorders after treatment with levodopa–carbidopa intestinal gel in Parkinson's disease
by: A. Contreras Chicote, et al.
Published: (2023-04-01)

Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
by: Yassine Noui, et al.
Published: (2021-09-01)

Frequency of adverse events in Levodopa‐carbidopa intestinal gel treatment: A retrospective real life study.
by: Donato Melchionda, et al.
Published: (2022-09-01)

Levodopa-Carbidopa: Um Caso Incomum de Intoxicação Medicamentosa Voluntária
by: Sara Aleixo Duarte, et al.
Published: (2024-04-01)

Acute Acalculous Cholecystitis in Severe Trauma Patients: A Single Center Experience
by: Jong Beom Kim, et al.
Published: (2015-10-01)

Brucellosis Presenting with Acute Acalculous Cholecystitis: A Case Report and Review of Literature
by: Hatice KÖSE, et al.
Published: (2017-06-01)

Comparison of two types of extension tubes for people with Parkinson’s disease in advanced treatment with levodopa–entacapone–carbidopa intestinal gel infusions: a prospective, crossover quality study
by: Bo Biering-Sörensen, et al.
Published: (2024-01-01)

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
by: Kye Won Park, et al.
Published: (2020-09-01)

A case of carbidopa/levodopa associated colitis mimicking inflammatory bowel disease
by: Michael J. Steel, et al.
Published: (2022-06-01)

Chronic acalculous cholecystitis and biliary dysfunction: how does clinical diagnosis affect management?
by: Yu. A. Kucheryavyy, et al.
Published: (2021-05-01)

Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib
by: Leonardo Gomes da Fonseca, et al.
Published: (2014-04-01)